Annual General Meeting of BioGaia

The Annual General Meeting of BioGaia AB (publ) on 10 May 2016 voted to approve the following resolutions:

  • adoption of the annual report
  • discharge from liability for the Board members and the Managing Director
  • a dividend of SEK 5.00 per share
  • re-election of Board members Jan Annwall, Ewa Björling, David Dangoor, Stefan Elving, Inger Holmström, Anthon Jahreskog, Brit Stakston and Paula Zeilon
  • re-election of David Dangoor as Board Chairman
  • re-election of the registered Accounting firm Deloitte AB
  • Board member compensation in an amount of SEK 300,000 to the Chairman and SEK 150,000 to each of the other Board members not employed by the company
  • auditors’ fee shall be paid according to approved account
  • regarding principles for remuneration and other terms of employment for senior executives in accordance with the Board’s proposal
  • regarding the Nominating Committee in accordance with the Nominating Committee’s proposal

Latest press releases from BioGaia
2016-05-10 BioGaia AB Interim management statement 1 January – 31 March 2016
2016-05-02 Yet another meta-analysis confirms the effectiveness of BioGaia’s probiotic in infantile colic
2016-04-27 BioGaia guarantees rights issue in IBT

For additional information please contact
Axel Sjöblad, Managing Director, BioGaia: +46 8 555 293 00

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of NASDAQ Stockholm main market. www.biogaia.com

About Us

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri, which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com If you need more information about BioGaia and our products please visit our website or download our press kit from: http://www.biogaia.com/press-material